Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
A pair of patients with Waldenstrom’s non-Hodgkins lymphoma (NHL) remain in complete remission (CR) after 7 and 15 months ...
ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...
Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...
A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant.
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.